Yaky Yanay, CEO of pioneering Israeli biotechnology company Pluri, speaks with B’nai B’rith CEO Dan Mariaschin about the range of next-generation cell-based products Pluri is creating to improve human wellbeing, increase sustainability, and advance solutions to humanity’s greatest challenges.

The Haifa-based company has its roots in regenerative medicine and plans to use its technology to continue driving cutting-edge medical research, and to create novel cell-based solutions for innovative initiatives in rapidly evolving sectors, including food tech, agri-tech and biologics.